���Ҵ�ý�ƽ������

Think Bioscience (“Think”), a synthetic biology company focused on developing small-molecule therapeutics that target difficult-to-drug proteins, has raised $17M in an oversubscribed Seed round. Think's foundational IP was developed by CEO Jerome Fox's research group at ���Ҵ�ý�ƽ������.

“For the industry, now is the time to solve this problem,” Wil Srubar, an associate professor at ���Ҵ�ý�ƽ������ and the lead researcher on the project, says in a news release. “We believe that we have one of the best solutions, if not the best solution, for the cement and concrete industry to address its carbon problem.”

Artimus builds actuator components for industries such as defense, automotive and medical devices. Its proprietary HASEL technology “already has shown incredible potential in many applications,” said CEO Tim Morrissey. “This capital will facilitate optimization of the technology for the best applications.”

SomaLogic, a leader in AI data-driven proteomics technology founded by Professor Larry Gold (MCDB), has entered into an agreement to acquire Palamedrix, Inc.—a move intended to accelerate the SomaScan Platform's utilization in global biopharma and academic markets.

Meati Foods, a Boulder-based company that uses mushroom root to make protein-packed cutlets, has received a fresh $150M capital injection. With the new funding, Meati’s first order of business is to complete its first production facility, known as a Mega Ranch, in Thornton.

The global quantum ecosystem leader has been named a winner in the "Product Innovation: Instrumentation & Test" category of the 2022 Best of Sensors Awards from Questex for Maxwell, a Quantum RF Sensor Platform. The awards honor the best in sensor technologies, people and companies.

The CU startup was recognized for their work towards less invasive tests with simple, user-generated results to empower people with direct knowledge of their health.

AbbVie and MBC BioLabs announced Think Bioscience as one of two winners of their 2022 Golden Ticket Competition. The award supports entrepreneurial scientists and emerging biotechnology start-ups to accelerate early drug discovery and innovation for the potential benefit of patients worldwide.

Formerly SweetSense, the CU spinout snagged $5.5 million in Series A funding to accelerate the development and adoption of its satellite-connected sensors for managing water, energy and agricultural resources.

Prometheus Materials "bio-cement," developed in a ���Ҵ�ý�ƽ������ lab, can lock away climate-warming gases inside the walls and foundations of future buildings.